Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
about
Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidenceAssociation between serum angiotensin-converting enzyme 2 levels and postoperative myocardial infarction following coronary artery bypass grafting.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injuryValsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2.Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure.Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models.Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.Angiotensin II receptor blocker reverses heart failure by attenuating local oxidative stress and preserving resident stem cells in rats with myocardial infarction
P2860
Q33586752-B23C9512-32EB-4733-9FF3-F5B2C928DAFBQ33706369-6F90EFDE-76BA-4F32-BEC2-21B4524DE12CQ34866649-38F11A89-8665-45CF-A21F-705C943D618CQ35908017-E2922C52-04F9-4CB1-A767-9A82837AC2FEQ37194713-43F57E39-43F2-475A-8FC1-A0BEC755F0E0Q38083745-D2E29A29-3845-4E84-8456-8F0DADE555C6Q38567063-71E8F3F5-9E20-4F09-8B23-E0D272C981A5Q46895349-0E8DD1B1-BE42-4034-84CF-35F81C823B5CQ55467665-0FB3F616-112A-45C3-996D-0A8D26FC3B57Q58776072-1096B12E-4D43-4A84-907E-DF56CBE0BAB5
P2860
Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination renin-angiotensin ...... future therapeutic directions.
@en
Combination renin-angiotensin ...... future therapeutic directions.
@nl
type
label
Combination renin-angiotensin ...... future therapeutic directions.
@en
Combination renin-angiotensin ...... future therapeutic directions.
@nl
prefLabel
Combination renin-angiotensin ...... future therapeutic directions.
@en
Combination renin-angiotensin ...... future therapeutic directions.
@nl
P2093
P2860
P356
P1433
P1476
Combination renin-angiotensin ...... future therapeutic directions.
@en
P2093
Elena Velkoska
Karen Griggs
Louise M Burrell
Luke J Burchill
Rachael G Dean
Sheila K Patel
P2860
P304
P356
10.1042/CS20120162
P407
P577
2012-12-01T00:00:00Z